Opevesostat (Merck). A first-in-class CYP11A1 inhibitor that shuts down androgen production at its source, opevesostat is in two phase 3 trials, OMAHA-003 and OMAHA-004, for metastatic ...

Prostate cancer has many treatment options and a highly effective screening process. This is what doctors what men to know ...

Higher saturated fat intake tied to greater mortality risk, likely due to cardiovascular d ...

Regular prostate cancer screening is not recommended for all men. Here's why.

The association is driven by higher rates of death from cardiovascular disease and other cancers over 13 years.

Researchers suggest choosing olive oil, nuts, seeds and avocados more often than foods high in animal or saturated fat. With ...

Men diagnosed with nonmetastatic prostate cancer can generally expect to live for many years after their diagnosis. However, ...

Prostate cancer screening, test interpretation and treatment decisions can be complex, particularly as new approaches to care ...

Dr. Cedrek McFadden shares the question he recommends men ask their doctors about prostate cancer screening and whether ...

Men with prostate cancer have a high risk of heart disease, especially when treated with hormone therapy. A large ...

A Southwest Louisiana surgeon is bringing advanced robotic surgeries and early screening awareness to Lake Charles, giving ...

Blue shoes took over Regions Field Thursday night as the Mike Slive Foundation hosted its 10th annual Blue Shoe Ball.